Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
98 participants
INTERVENTIONAL
2014-08-04
2015-02-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of Toothpaste Tablets on Plaque, Gingival Health and Caries Experiences
NCT07124533
To Investigate the Clinical Efficacy of an Experimental Toothpaste
NCT01079910
A Study to Measure the Effect of a Toothpaste Containing Proteins and Enzymes and a Fluoride Toothpaste on Gingival Health
NCT06932211
A Pilot Study to Evaluate a Molecular Method for Plaque
NCT02574221
To Evaluate the Efficacy of Probiotics Toothpastes in Improvement of Gingivitis and Prevention of Periodontal Diseases Via Modulating the Oral Microbiota
NCT04190485
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
98 patients were assessed for eligibility. Since two patients did not meet the inclusion criteria, 96 subjects were randomly assigned to either the test group.The test group was provided a liquid toothpaste and a control group received placebo. At the end of the study, results were analyzed for 87 patients : 42 in the test group and 45 in the control group .
The study protocol requested 4 visits- once every two weeks-of each subjects in the center. At the baseline, subjects were randomly allocated to the test group or the control group. Scaling and tooth brushing instruction were performed and all of the clinical parameters were evaluated. At the 2- and 4-week examinations, clinical parameters of GI, PI were evaluated and at the 6-week examination, all of the clinical parameters were evaluated.
Also, Microbiological quantitative analysis of this procedure was performed at the baseline and 6-week examinations.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
DA-5502 liquid toothpaste
SMFP 760mg, CPC 50mg, tocopherol acetate 10mg, panthenol 100mg, Dipotassium glycyrrhizinate 20mg.
everyday 3 times for 6 weeks
DA-5502 liquid toothpaste
6 weeks study, brush three times daily, liquid toothpaste
placebo
no active ingredients
everyday 3 times for 6 weeks
placebo
same flavor solution, brush three times daily
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
DA-5502 liquid toothpaste
6 weeks study, brush three times daily, liquid toothpaste
placebo
same flavor solution, brush three times daily
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Minimum of 20 uncrowned permanent natural teeth (excluding third molars).
* Initial gingivitis index of 1.1\~2.0 as determined by the use of the Loe and Silness Gingival Index.
* Signed Informed Consent Form.
Exclusion Criteria
* smoker
* Chronic disease (uncontrolled diabetes, liver disease, heart disease, kidney disease..)
* subject who had hemorrhagic medical history or who take antiplatelet agent or anticoagulant
* subject who need antibiotics for preventive administration
* subjects who had preventive treatment or treatment for periodontitis in the last three months
* Use of orthodontic appliances.
* Pregnant women or women who are breast feeding.
* Previous participation in any other clinical trial in the last 30 days
* Judged unsuitable by investigators for other reasons.
20 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dong-A Pharmaceutical
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Chang-Sung Kim, Ph.D
Role: STUDY_DIRECTOR
Department of Periodontology, Research Institute for Periodontal Regeneration, College of Dentistry, Yonsei University
References
Explore related publications, articles, or registry entries linked to this study.
Rawlinson A, Pollington S, Walsh TF, Lamb DJ, Marlow I, Haywood J, Wright P. Efficacy of two alcohol-free cetylpyridinium chloride mouthwashes - a randomized double-blind crossover study. J Clin Periodontol. 2008 Mar;35(3):230-5. doi: 10.1111/j.1600-051X.2007.01187.x. Epub 2008 Jan 5.
Hu D, Li X, Sreenivasan PK, DeVizio W. A randomized, double-blind clinical study to assess the antimicrobial effects of a cetylpyridinium chloride mouth rinse on dental plaque bacteria. Clin Ther. 2009 Nov;31(11):2540-8. doi: 10.1016/j.clinthera.2009.11.004.
Silva MF, dos Santos NB, Stewart B, DeVizio W, Proskin HM. A clinical investigation of the efficacy of a commercial mouthrinse containing 0.05% cetylpyridinium chloride to control established dental plaque and gingivitis. J Clin Dent. 2009;20(2):55-61.
Charles CA, McGuire JA, Sharma NC, Qaqish J. Comparative efficacy of two daily use mouthrinses: randomized clinical trial using an experimental gingivitis model. Braz Oral Res. 2011 Jul-Aug;25(4):338-44. doi: 10.1590/s1806-83242011000400010.
Hernandez-Cott PL, Elias Boneta A, Stewart B, DeVizio W, Proskin HM. Clinical investigation of the efficacy of a commercial mouthrinse containing 0.05% cetylpyridinium chloride in reducing dental plaque. J Clin Dent. 2009;20(2):39-44.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DA-5502_301
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.